RarePipelinepeopleInnovationCollaborationCareersFinance Advance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Financial documents

Shareholders

Shareholders

Top 10 shareholders as of December 31, 2022

NameNumber of sharesOwnership in pct
Redmile Group, LLC10 896 55320.8%
Försäkrings AB Avanza Pension2 209 7834,2%
Fjärde AP-Fonden (AP 4)2 207 3974.2%
Nexttobe AB2 155 3794,1%
Olausson, Thomas1 917 0003,7%
Tredje AP-Fonden (AP 3)1 389 6502,6%
Braidwell, L.P.974 5281,9%
Handelsbanken Asset Management908 2661,7%
C WorldWide Asset Management799 7491,5%
Heights Capital Management, Inc.667 1691,3%
Other28 318 48854,0%
Total52 443 962100.0%

Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).

Hansa Biopharma had approximately 18,000 shareholders as of September 30, 2022.

Classification of ownership as per Dec 31, 2022

Region

53%
25%
22%

Category

57%
32%
7%
4%